Article
DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis.
Nature communications - 19 Jun 2018
Kular Lara, Liu Yun, Ruhrmann Sabrina, Zheleznyakova Galina, Marabita Francesco, Gomez-Cabrero David, James Tojo, Ewing Ewoud, Lindén Magdalena, Górnikiewicz Bartosz, Aeinehband Shahin, Stridh Pernilla, Link Jenny, Andlauer Till F M, Gasperi Christiane, Wiendl Heinz, Zipp Frauke, Gold Ralf, Tackenberg Björn, Weber Frank, Hemmer Bernhard, Strauch Konstantin, Heilmann-Heimbach Stefanie, Rawal Rajesh, Schminke Ulf, Schmidt Carsten O, Kacprowski Tim, Franke Andre, Laudes Matthias, Dilthey Alexander T, Celius Elisabeth G, Søndergaard Helle B, Tegnér Jesper, Harbo Hanne F, Oturai Annette B, Olafsson Sigurgeir, Eggertsson Hannes P, Halldorsson Bjarni V, Hjaltason Haukur, Olafsson Elias, Jonsdottir Ingileif, Stefansson Kari, Olsson Tomas, Piehl Fredrik, Ekström Tomas J, Kockum Ingrid, Feinberg Andrew P, Jagodic Maja
Abstract excerpt
The human leukocyte antigen (HLA) haplotype DRB1*15:01 is the major risk factor for multiple sclerosis (MS). Here, we find that DRB1*15:01 is hypomethylated and predominantly expressed in monocytes among carriers of DRB1*15:01. A differentially methylated region (DMR) encompassing HLA-DRB1 exon 2 is particularly affected and displays methylation-sensitive regulatory properties in vitro. Causal inference and...
Topics
- Adult
- Aged
- Cells, Cultured
- Cohort Studies
- DNA Methylation
